Fibrin formation and lysis studies in dengue virus infection

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 7, 2009, Pages 575-582

  Marchi, Rita ^a   Nagaswami, Chandrasekaran ^b   Weisel, John W ^b  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

D dimer; Dengue virus infection; Fibrin formation; Fibrinolysis; Scanning electron microscopy

Indexed keywords

ALBUMIN; D DIMER; FIBRINOGEN; FIBRIN; FIBRIN DEGRADATION PRODUCT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISSOLUTION; DYSFIBRINOGENEMIA; FIBRIN FORMATION; FIBRIN POLYMERIZATION; FIBRINOLYSIS; HUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SCANNING ELECTRON MICROSCOPY; SEROTYPE; THROMBIN TIME; TURBIDITY; BLOOD; BLOOD CLOTTING; METABOLISM; ULTRASTRUCTURE;

BLOOD COAGULATION; DENGUE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; HUMANS; THROMBIN TIME;

EID: 70349826655     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32832fb1cf     Document Type: Article

References (37)

1. Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006; 368:170-173.
2. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239:476-481.
3. Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev 1990; 3:376-396.
4. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480-496.
5. Harris E, Videa E, Pé rez L, Sandoval E, Té llez Y, Pé rez ML, et al. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 2000; 63:5-11.
6. Bhakdi S, Kazatchkine MD. Pathogenesis of dengue: an alternative hypothesis. Southeast Asian J Trop Med Public Health 1990; 21:652-667.
7. Bielefeldt-Ohmann H. Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends Microbiol 1997; 5:409-413.
8. Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology 1999; 257:1-6.
9. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet 1998; 352:971-977.
10. Srichaikul T, Nimmanitaya S, Artchararit N, Siriasawakul T, Sungpeuk P. Fibrinogen metabolism and disseminated intravascular clotting in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 6:525-532.
11. Bhamarapravati N. Hemostatic defects in dengue hemorrhagic fever. Rev Infect Dis 1989; 11 (Suppl 4):S826-S829.
12. Marcel L, van Gorp ECM, ten Cate H. Disseminated intravascular coagulation. In: Handin RI, Lux SE, Stossel TP, editors. Blood. Principles and practice of haematology, 2nd edn. Philadelphia: Lippincott Williams and Wilkins; 2003. pp. 1275-1301.
13. Mairuhu AT, MacGillavry MR, Setiati TE, Soemantri A, ten Gates H, Brandjes DP, et al. Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis 2003; 3:33-41.
14. Chungue E, Poli L, Roche C, Gestas P, Glaziou P, Markoff LJ. Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection. J Infect Dis 1994; 170:1304-1307.
15. Huang YH, Chang BI, Lei HY, Liu HS, Liu CC, Wu HL, et al. Antibodies against dengue virus E protein peptide bind to human plasminogen and inhibit plasmin activity. Clin Exp Immunol 1997; 110:35-40.
16. Krishnamurti C, Wahl LM, Alving BM. Stimulation of plasminogen activator inhibitor activity in human monocytes infected with dengue virus. Am J Trop Med Hyg 1989; 40:102-107.
17. Monroy V, Ruiz BH. Participation of the dengue virus in the fibrinolytic process. Virus Genes 2000; 21:197-208.
18. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545-551.
19. Ingram GIC. The determination of plasma fibrinogen by the clot weight method. Biochem J 1952; 51:583-585.
20. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15:45-52.
21. Schägger H, Von Jagow G. Tricine-sodium dodecyl sulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987; 166:368-379.
22. Kazal LA, Amsel S, Miller OP, Tocantins LM. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Biol Med 1963; 113:989-994.
23. Marchi R, Ló pez YR, Nagaswami S, Masova L, Pulido A, Ló pez JM, et al. Hemostatic changes related to fibrin formation and fibrinolysis during the first trimester in normal pregnancy and in recurrent miscarriage. Thromb Haemost 2007; 97:552-557.
24. Langer BG, Weisel JW, Dinauer PA, Nagaswami C, Bell WR. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem 1988; 263:15056-15063.
25. Platonova TN, Musialkovskaia AA, Tolstykh VM, Belitser VA. Inhibition of fibrin assembly by fragment D and its dimer derived from fibrinogen and stabilized fibrin. Evidence for the two-step type of inhibition. Biokhimiia 1980; 45:1780-1787.
26. Hermans J, McDonagh J. Fibrin: structure and interactions. Semin Thromb Hemost 1982; 8:11-24.
27. Nimmannitya S. Clinical spectrum andmanagement of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987; 18:392-397.
28. Hathirat P, Isarangkura P, Srichaikul T, Suvatte V, Mitrakul C. Abnormal hemostasis in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1993; 24:80-85.
29. Sosothikul D, Seksarn P, Pongsewalak S, Thisyakorn U, Lusher J. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost 2007; 97:627-634.
30. Huang YH, Liu CC, Wang ST, Lei HY, Liu HS, Lin YS, et al. Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol 2001; 63:247-251.
31. van Gorp EC, Setiati TE, Mairuhu AT, Suharti C, ten Cate H, Dolmans WM, et al. Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever. J Med Virol 2002; 67:549-554.
32. van Gorp EC, Minnema MC, Suharti C, Mairuhu AT, Brandjes DP, ten Cate H, et al. Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever. Br J Haematol 2001; 113:94-99.
33. Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, et al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 vietnamese children with dengue shock syndrome. Clin Infect Dis 2002; 35:277-285.
34. Garman AJ, Smith RA. The binding of plasminogen to fibrin: evidence for plasminogen-bridging. Thromb Res 1982; 27:311-320.
35. Petersen LC, Suenson E. Effect of plasminogen and tissue-type plasminogen activator on fibrin gel structure. Fibrinolysis 1991; 5:51-59.
36. Meh DA, Mosesson MW, DiOrio JP, Siebenlist KR, Hernandez I, Amrani DL, et al. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clotlysis. Blood Coagul Fibrinolysis 2001; 12:627-637.
37. Veklich Y, Francis CH, White J, Weisel JW. Structural studies of fibrinolysis by electron microscopy. Blood 1998; 92:4721-4729.